NKTR Earnings Nektar Therapeutics
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | -2.96 | 2026-08-14 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.82 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -9.73 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | -8.14 | 2025-11-07 | 10-Q |
| Q2 2026 | 2025-06-30 | -6.57 | 2026-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -3.62 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -8.68 | 2026-03-13 | 10-K |
| Q3 2025 | 2024-09-30 | -9.27 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | -6.63 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.19 | 2025-05-09 | 10-Q |
| FY 2024 | 2023-12-31 | -1.45 | 2025-03-14 | 10-K |
| Q3 2024 | 2023-09-30 | -1.23 | 2024-11-08 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.99 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.73 | 2024-05-10 | 10-Q |
| FY 2023 | 2022-12-31 | -1.97 | 2024-03-05 | 10-K |
| Q3 2023 | 2022-09-30 | -1.65 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.34 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.49 | 2023-05-10 | 10-Q |
| FY 2023 | 2021-12-31 | -2.86 | 2024-03-05 | 10-K |
| Q3 2022 | 2021-09-30 | -2.07 | 2022-11-04 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.37 | 2022-08-05 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.68 | 2022-05-06 | 10-Q |
| FY 2022 | 2020-12-31 | -2.49 | 2023-02-28 | 10-K |
| FY 2021 | 2020-09-30 | -0.61 | 2022-03-01 | 10-K |
| FY 2021 | 2020-06-30 | -0.45 | 2022-03-01 | 10-K |
| FY 2021 | 2020-03-31 | -0.78 | 2022-03-01 | 10-K |
| FY 2021 | 2019-12-31 | -2.52 | 2022-03-01 | 10-K |
| FY 2020 | 2019-09-30 | -0.56 | 2021-02-26 | 10-K |
| FY 2020 | 2019-06-30 | -0.63 | 2021-02-26 | 10-K |
| FY 2020 | 2019-03-31 | -0.69 | 2021-02-26 | 10-K |
| FY 2020 | 2018-12-31 | 3.78 | 2021-02-26 | 10-K |
| FY 2019 | 2018-09-30 | -0.56 | 2020-02-28 | 10-K |
| FY 2019 | 2018-06-30 | 5.33 | 2020-02-28 | 10-K |
| FY 2019 | 2018-03-31 | -0.60 | 2020-02-28 | 10-K |
| FY 2019 | 2017-12-31 | -0.62 | 2020-02-28 | 10-K |
| FY 2018 | 2017-09-30 | 0.37 | 2019-03-01 | 10-K |
| FY 2018 | 2017-06-30 | -0.39 | 2019-03-01 | 10-K |
| FY 2018 | 2017-03-31 | -0.42 | 2019-03-01 | 10-K |
| FY 2018 | 2016-12-31 | -1.10 | 2019-03-01 | 10-K |
| FY 2017 | 2016-09-30 | -0.32 | 2018-03-01 | 10-K |
| FY 2017 | 2016-06-30 | -0.36 | 2018-03-01 | 10-K |
| FY 2017 | 2016-03-31 | -0.14 | 2018-03-01 | 10-K |
| FY 2016 | 2015-12-31 | -0.40 | 2017-03-01 | 10-K |
| FY 2016 | 2015-09-30 | -0.06 | 2017-03-01 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.